PATENT CLAIM ANALYSIS

Application Number: 16412284
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "562000"]

Abstract:
A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed.

Claim (Index 19):
The method of  claim 18 , further comprising determining if the patient has achieved clinically significant improvement in liver function over the course of the 20 hour treatment, and if not, continuing the administration of acetylcysteine to the patient beyond 21 hours to achieve significant clinical improvement in liver function.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13188152', '14225345', '13757721', '14153978', '13406175']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7907387271786197
- 35 USC 102 Novelty (BERT): 0.5618810702541859
- Combined Prediction Score: 0.7678529614861763
- Mean Citation Score: 380.933756
- Max Citation Score: 459.8708
- Similarity Product: 355.409437763524

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test